United States (US) Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2029

Pharmaceuticals in the United States industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2019-24, and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

– The pharmaceutical market includes sales of both prescriptions and over-the-counter (OTC) drugs. The market scope does not cover consumer healthcare and animal health products.

– The US pharmaceuticals market recorded revenues of $569.3 billion in 2024, representing a compound annual growth rate (CAGR) of 3.8% between 2019 and 2024.

– The oncology drugs segment accounted for the market's largest proportion in 2024, with total revenues of $101.0 billion, equivalent to 17.7% of the market's overall value.

– The US pharmaceuticals market witnessed healthy growth in 2024, registering an annual growth of 5.0%.

Scope

– Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in the United States

– Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in the United States

– Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance

– Add weight to presentations and pitches by understanding the future growth prospects of the United States pharmaceuticals market with five year forecasts by both value and volume

Reasons to buy

- What was the size of the United States pharmaceuticals market by value in 2024?

- What will be the size of the United States pharmaceuticals market in 2029?

- What factors are affecting the strength of competition in the United States pharmaceuticals market?

- How has the market performed over the last five years?

- Who are the top competitors in the United States's pharmaceuticals market?

Companies mentioned

Johnson & Johnson

Merck & Co Inc

AbbVie Inc

Pfizer Inc

Table of Contents

Table of Contents

1 Executive Summary

1.1. Market value

1.2. Market value forecast

1.3. Category segmentation

1.4. Geography segmentation

1.5. Market rivalry

1.6. Competitive landscape

2 Market Overview

2.1. Market definition

2.2. Market analysis

3 Market Data

3.1. Market value

4 Market Segmentation

4.1. Category segmentation

4.2. Geography segmentation

5 Market Outlook

5.1. Market value forecast

6 Five Forces Analysis

6.1. Summary

6.2. Buyer power

6.3. Supplier power

6.4. New entrants

6.5. Threat of substitutes

6.6. Degree of rivalry

7 Competitive Landscape

7.1. Who are the leading players?

7.2. What are the strengths of the leading players?

7.3. What are the recent developments in the market?

8 Company Profiles

8.1. Johnson & Johnson

8.2. Merck & Co Inc

8.3. AbbVie Inc

8.4. Pfizer Inc

9 Macroeconomic Indicators

9.1. Country data

10 Appendix

10.1. Methodology

10.2. Industry associations

10.3. Related MarketLine research

10.4. About MarketLine

List of Tables

List of Tables

Table 1: United States pharmaceuticals market value: $ million, 2019–24

Table 2: United States pharmaceuticals market category segmentation: % share, by value, 2019–24

Table 3: United States pharmaceuticals market category segmentation: $ million, 2019-24

Table 4: United States pharmaceuticals market geography segmentation: $ million, 2024

Table 5: United States pharmaceuticals market value forecast: $ million, 2024–29

Table 6: Johnson & Johnson: Key Facts

Table 7: Johnson & Johnson: Annual Financial Ratios

Table 8: Johnson & Johnson: Key Employees

Table 9: Merck & Co Inc: Key Facts

Table 10: Merck & Co Inc: Annual Financial Ratios

Table 11: Merck & Co Inc: Key Employees

Table 12: AbbVie Inc: Key Facts

Table 13: AbbVie Inc: Annual Financial Ratios

Table 14: AbbVie Inc: Key Employees

Table 15: AbbVie Inc: Key Employees Continued

Table 16: Pfizer Inc: Key Facts

Table 17: Pfizer Inc: Annual Financial Ratios

Table 18: Pfizer Inc: Key Employees

Table 19: Pfizer Inc: Key Employees Continued

Table 20: United States Size of Population (Million), 2020–24

Table 21: United States Real GDP (Constant 2010 Prices, $ Billion), 2020–24

Table 22: United States GDP (Current Prices, $ Billion), 2020–24

Table 23: United States Inflation, 2020–24

Table 24: United States Consumer Price Index (Absolute), 2020–24

Table 25: United States Exchange Rate, 2019–24

List of Figures

List of Figures

Figure 1: United States pharmaceuticals market value: $ million, 2019–24

Figure 2: United States pharmaceuticals market category segmentation: $ million, 2019-24

Figure 3: United States pharmaceuticals market geography segmentation: % share, by value, 2024

Figure 4: United States pharmaceuticals market value forecast: $ million, 2024–29

Figure 5: Forces driving competition in the pharmaceuticals market in the United States, 2024

Figure 6: Drivers of buyer power in the pharmaceuticals market in the United States, 2024

Figure 7: Drivers of supplier power in the pharmaceuticals market in the United States, 2024

Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in the United States, 2024

Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in the United States, 2024

Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in the United States, 2024

    Pricing

Quick Buy
Add to basket Enquire before buying

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports